Unsaturated Polyester Resin (UPR) Market Is Expected To Be

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Unsaturated Polyester Resin (UPR) Market Is Expected To Be Worth $11.37 Billion by 2020: New Report By Grand View Research, Inc.

San Francisco, California, Nov. 26, 2014 (GLOBE NEWSWIRE) -- Global Unsaturated Polyester Resin (UPR) market is expected to reach USD 11.37 billion by 2020, according to a new study by Grand View Research, Inc. Growing construction industry as a result of industrialization in emerging countries including China, India and Brazil is expected to increase Fiberglass Reinforced Plastics (FRP) demand. UPR is extensively used in the manufacturing of FRP and is expected to witness growth on account of growing FRP use in construction. Increasing use of tanks & pipes in the chemical industry is expected to propel UPR demand over the forecast period.

Building & construction was the most dominant end-use of UPR with demand estimated at over 1,100.0 kilo tons in 2013 owing to increasing FRP usage. Increasing application scope in industries including marine, aerospace, automotive and chemical is expected to result in high demand for UPR over the next six years. UPR use in tanks and pipe is expected to be a key area of development for the market over the forecast period.

Get More Details About Unsaturated Polyester Resin (UPR) Market: http://www.grandviewresearch.com/industry-ana...upr-market

Further key findings from the study suggest:

  • Global UPR demand was estimated at 4,509.3 kilo tons in 2013 and is expected to exceed 6,800.0 kilo tons by 2020, growing at a CAGR of 6.3% from 2014 to 2020.
  • Orthopthalic resins are widely used in transport, construction and marine industries owing to low cost as compared to DCPD resins. However, the latter are increasingly gaining acceptance due to low VOC emissions and are estimated to gain share over the next six years. DCPD resins are expected to witness fastest growth at an estimated CAGR of 6.7% from 2014 to 2020.
  • Construction industry is expected to witness high UPR demand primarily due to lightweight and high sustainability of FRP. Increased infrastructure spending by emerging countries is expected to positively impact UPR demand.
  • Asia Pacific accounted for more than 50% of market volume share in 2013 owing to high end-use industry growth. Emerging economies of India and China are experiencing rapid industrialization resulting in infrastructure improvement and increased marine, transport, aerospace and automobile industries which are key factors responsible for high market share.
  • UPR market has numerous domestic participants catering to end-use industries in their respective region. The market is fragmented on a global level with the top four companies accounting for less than 25% of the market in 2013. Key global participants in the market include BASF, Dow Chemicals, Ashland and CCP Composites.

For the purpose of this study, Grand View Research has segmented the global UPR market on the basis of product, end-use and region:

UPR Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
    • Orthopthalic
    • Isopthalic
    • DCPD
    • Others
UPR End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
    • Building & Construction
    • Tanks & Pipes
    • Electrical
    • Marine
    • Transport
    • Artificial Stones
    • Others
UPR Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
    • North America
    • Europe
    • Asia Pacific
    • RoW

Read Full Research Report On Global Unsaturated Polyester Resin (UPR) Market: http://www.grandviewresearch.com/industry-ana...upr-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: Grand View Research

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 0

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 141

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy

Updated Category News Views 0

A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...

Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 79

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 131

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 151

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 30

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 24

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 190

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading

Top 5 Most Recently Viewed Articles

DallasNews Shareholders Urged to Support Merger Deal with Hearst

Updated Category News Views 101

Overview of the DallasNews and Hearst Merger DallasNews Corporation, the parent company of The Dallas Morning News, has proposed a significant merger with Hearst, a prominent media organization. This merger offers an enticing cash value of $15.00 per share, bringing impressive benefits to shareholders. Recently, Glass Lewis, an independent proxy advisory firm, recommended...

Continue Reading
GitLab Director Karen Blasing's Recent Stock Transactions Explained

Updated Category News Views 154

Analyzing the Recent Insider Trading at GitLab GitLab Inc. (NASDAQ:GTLB) has recently drawn the attention of investors and market analysts due to stock transactions made by its director, Karen Blasing. A recent filing with the U.S. Securities and Exchange Commission revealed that Blasing sold a considerable amount of her stock holdings, totaling more than $173,000....

Continue Reading
Avenue Living's Strategic $350 Million Debenture Offering

Updated Category News Views 202

Avenue Living Announces $350 Million Senior Unsecured Debenture Offering Avenue Living (2014) LP has recently announced a significant financial move with a $350 million offering of Series B senior unsecured debentures. This opportunity is set to be priced at par and is due by September 25, 2028, indicating a long-term strategy for the company’s financing needs. Details...

Continue Reading
Fagron Reports Strong Financial Growth with Strategic Outlook

Updated Category News Views 349

Fagron's Remarkable Financial Performance Fagron, a global leader in pharmaceutical compounding, recently showcased its impressive results for the period ending December 31, 2024. The company’s financial achievements highlight significant growth across various sectors and regions in the pharmaceutical industry, reinforcing its commitment to excellence and innovation....

Continue Reading
Dizal's Sunvozertinib Receives Breakthrough Therapy Designation

Updated Category News Views 444

Dizal's Sunvozertinib Achieves Breakthrough Therapy Designation Dizal, a biopharmaceutical company dedicated to developing innovative cancer and immunological therapies, recently announced an important milestone. The Center for Drug Evaluation of China's National Medical Products Administration has granted Breakthrough Therapy Designation for sunvozertinib, aimed at...

Continue Reading